GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Asset Turnover

PT Indofarma Tbk (ISX:INAF) Asset Turnover : 0.05 (As of Sep. 2023)


View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. PT Indofarma Tbk's Revenue for the three months ended in Sep. 2023 was Rp81,737 Mil. PT Indofarma Tbk's Total Assets for the quarter that ended in Sep. 2023 was Rp1,525,063 Mil. Therefore, PT Indofarma Tbk's Asset Turnover for the quarter that ended in Sep. 2023 was 0.05.

Asset Turnover is linked to ROE % through Du Pont Formula. PT Indofarma Tbk's annualized ROE % for the quarter that ended in Sep. 2023 was 409.70%. It is also linked to ROA % through Du Pont Formula. PT Indofarma Tbk's annualized ROA % for the quarter that ended in Sep. 2023 was -18.71%.


PT Indofarma Tbk Asset Turnover Historical Data

The historical data trend for PT Indofarma Tbk's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Asset Turnover Chart

PT Indofarma Tbk Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.07 0.96 1.11 1.56 0.65

PT Indofarma Tbk Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.14 0.11 0.12 0.05

Competitive Comparison of PT Indofarma Tbk's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Indofarma Tbk's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's Asset Turnover distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's Asset Turnover falls into.



PT Indofarma Tbk Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

PT Indofarma Tbk's Asset Turnover for the fiscal year that ended in Dec. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=1144108.231/( (2011879.396+1534000.447)/ 2 )
=1144108.231/1772939.9215
=0.65

PT Indofarma Tbk's Asset Turnover for the quarter that ended in Sep. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=81736.853/( (1559064.75+1491062.01)/ 2 )
=81736.853/1525063.38
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


PT Indofarma Tbk  (ISX:INAF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

PT Indofarma Tbk's annulized ROE % for the quarter that ended in Sep. 2023 is

ROE %**(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-285415.416/-69663.8365
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-285415.416 / 326947.412)*(326947.412 / 1525063.38)*(1525063.38/ -69663.8365)
=Net Margin %*Asset Turnover*Equity Multiplier
=-87.3 %*0.2144*-21.8918
=ROA %*Equity Multiplier
=-18.71 %*-21.8918
=409.70 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

PT Indofarma Tbk's annulized ROA % for the quarter that ended in Sep. 2023 is

ROA %(Q: Sep. 2023 )
=Net Income/Total Assets
=-285415.416/1525063.38
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-285415.416 / 326947.412)*(326947.412 / 1525063.38)
=Net Margin %*Asset Turnover
=-87.3 %*0.2144
=-18.71 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


PT Indofarma Tbk Asset Turnover Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Indofarma Tbk (ISX:INAF) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines